Human platelets release TGFBIp in acute myocardial infarction

Area of Science:

• Cardiovascular Biology
• Hematology
• Thrombosis Research

Background:

• Transforming growth factor-β-induced protein (TGFBIp) is known to be released from activated platelets and linked to pro-thrombotic events.
• The specific role of TGFBIp in acute coronary syndrome (ACS), particularly concerning platelet function, remained largely uninvestigated.

Purpose of the Study:

• To investigate the release of TGFBIp from platelets in patients with myocardial infarction (MI).
• To elucidate the functional effects of TGFBIp on platelet activation, adhesion, rolling, and transmigration.
• To determine the presence of TGFBIp in arterial vessels of patients with ACS.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) and immunoblotting were used to quantify platelet TGFBIp levels.
• Flow chamber experiments assessed TGFBIp-induced platelet adhesion and rolling under physiological flow conditions.
• Transwell assays evaluated the chemotactic effects of TGFBIp on platelets.
• Immunohistochemistry was employed to detect TGFBIp and GPVI in human arterial vessel walls.

Main Results:

• Platelet TGFBIp release was significantly elevated in MI patients and correlated with the severity of acute coronary syndromes (STEMI, NSTEMI).
• Activated platelets release TGFBIp, which in turn activates platelets, promoting rolling and adherence under flow, similar to collagen.
• TGFBIp significantly enhanced platelet transmigration, and deposits of TGFBIp were observed in the arterial vessel walls.

Conclusions:

• Platelet-derived TGFBIp is significantly increased in myocardial infarction and contributes to acute coronary syndromes.
• TGFBIp exhibits platelet-activating, pro-adhesive, and pro-migratory properties, potentially driving coronary vascular inflammation and MI development.